SARS-CoV-2 Spike RBD Protein, His Tag (LF.7) (MALS verified)

Numéro de produit/spécification
Prix
Availability
Qté
SPD-S52Hg-100ug
$399.00
In Stock - Delivery in 2 weeks
SPD-S52Hg-1mg (500ug X 2)
$2,670.00
In Stock - Delivery in 2 weeks
SPD-S52Hg
Montant du produit :
$ 0
0
Ajouter au panier
Suggestion de nouveau produit Request Quote
Contact Us
Contact Us
Montant du produit:
$ 0
0
Ajouter au panier
  • Détails du produit
  • Affichage des données
  • Reviews & Citations
  • Important Statement
  • Resources
Synonyms

Spike, S protein RBD, Spike glycoprotein Receptor-binding domain, S glycoprotein RBD, Spike protein RBD

Source

SARS-CoV-2 Spike RBD Protein, His Tag (LF.7) (SPD-S52Hg) is expressed from human 293 cells (HEK293). It contains AA Arg 319 - Lys 537 (Accession # QHD43416.1 (I332V, G339H, R346T, K356T, S371F, S373P, S375F, T376A, R403K, D405N, R408S, K417N, N440K, K444R, G446S, N450D, L452W, L455S, F456L, N460K, S477N, T478K, N481K, E484K, F486P, Q498R, N501Y, Y505H)).

Predicted N-terminus: Arg 319

Molecular Characterization

This protein carries a polyhistidine tag at the C-terminus.

The protein has a calculated MW of 26.7 kDa. The protein migrates as 35-43 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

Endotoxin

Less than 1.0 EU per μg by the LAL method / rFC method.

Purity

>90% as determined by SDS-PAGE.

>90% as determined by SEC-MALS.

Formulation

Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

Contact us for customized product form or formulation.

Reconstitution

Please see Certificate of Analysis for specific instructions.

For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

Shipping and Storage

This product is shipped at ambient temperature.

For long term storage, the product should be stored at lyophilized state at -20°C or lower.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:
  • -20°C to -70°C for 12 months in lyophilized state;
  • -70°C for 3 months under sterile conditions after reconstitution.

Introduction de fond

The SARS‑CoV‑2 lineage LF.7 is a subvariant within the JN.1 family, identified through genomic surveillance in 2024–2025. It carries multiple Spike protein mutations, some within the receptor‑binding domain, potentially affecting antibody recognition and viral fitness. LF.7 and its sublineages (e.g., LF.7.2.1) have been detected across several regions, showing moderate growth advantage over earlier strains. Preliminary studies suggest certain mutations may enhance immune evasion, though impacts on ACE2 binding vary. Continuous monitoring is recommended to assess its epidemiological significance, vaccine effectiveness, and role in ongoing SARS‑CoV‑2 evolution.